HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: fj.06-7070comv1 21/12/3338    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bondesen, B. A. Articles by Pavlath, G. K. Search for Related Content PubMed PubMed Citation Articles by Bondesen, B. A. Articles by Pavlath, G. K.

Inhibition of myoblast migration by prostacyclin is associated with enhanced cell fusion

Brenda A. Bondesen^*, Kristen A. Jones^*, Wayne C. Glasgow and Grace K. Pavlath^*,1

^* Department of Pharmacology, Emory University, Atlanta, Georgia, USA; and

Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, Georgia, USA

¹Correspondence: Emory University School of Medicine, Department of Pharmacology, Rm. 5027, O.W. Rollins Research Bldg., Atlanta, GA 30322, USA. E-mail: gpavlat{at}emory.edu

Satellite cells are stem cells that are critical for the formation and growth of skeletal muscle during myogenesis. To differentiate and fuse, proliferating satellite cells or myoblasts must migrate and establish stable cell-cell contacts. However, the factors that regulate myoblast migration and fusion are not understood completely. We have identified PGI₂ as a novel regulator of myogenesis in vitro. PGI₂ is a member of the family of prostaglandins (PG), autocrine/paracrine signaling molecules synthesized via the cyclooxygenase-1 and -2 pathways. Primary mouse muscle cells both secrete PGI₂ and express the PGI₂ receptor, IP, at various stages of myogenesis. Using genetic and pharmacological approaches, we show that PGI₂ is a negative regulator of myoblast migration that also enhances cell fusion. Thus, PGI₂ may act as a "brake" on migrating cells to facilitate cell-cell contact and fusion. Together, our results highlight the importance of the balance between positive and negative regulators in cell migration and myogenesis. This work may have implications for migration of other populations of adult stem cells and/or cells that undergo fusion.—Bondesen, B. A., Jones, K. A., Glasgow, W. C., Pavlath, G. K. Inhibition of myoblast migration by prostacyclin is associated with enhanced cell fusion.

Key Words: prostaglandins • myogenesis • muscle repair

This article has been cited by other articles:

				G.-U. Bae, U. Gaio, Y.-J. Yang, H.-J. Lee, J.-S. Kang, and R. S. Krauss Regulation of Myoblast Motility and Fusion by the CXCR4-associated Sialomucin, CD164 J. Biol. Chem., March 28, 2008; 283(13): 8301 - 8309. [Abstract] [Full Text] [PDF]

				T. A. Trappe, C. C. Carroll, B. Jemiolo, S. W. Trappe, S. Dossing, M. Kjaer, and S. P. Magnusson Cyclooxygenase mRNA expression in human patellar tendon at rest and after exercise Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R192 - R199. [Abstract] [Full Text] [PDF]